Marianne Budde

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine

Maria J.W.D. Vosjan, Lars R. Perk, Gerard W.M. Visser et al. · Nature Protocols · 2010 · 440 citations

Medicine, Nuclear Medicine, Radiology +14

Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

Bernard M. Tijink, Toon Laeremans, Marianne Budde et al. · Molecular Cancer Therapeutics · 2008 · 294 citations

Pharmacy, Oncology, Pharmaceutics +17

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

Lars R. Perk, Maria J.W.D. Vosjan, Gerard W.M. Visser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 215 citations · Full text

Medicine, Immunology, Nuclear Medicine +17

Alkyl-lysophospholipid Accumulates in Lipid Rafts and Induces Apoptosis via Raft-dependent Endocytosis and Inhibition of Phosphatidylcholine Synthesis

Arnold H. van der Luit, Marianne Budde, Paula Ruurs et al. · Journal of Biological Chemistry · 2002 · 164 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage

Jeroen DeGroot, Nicole Verzijl, Kim M. G. Jacobs et al. · Osteoarthritis and Cartilage · 2001 · 121 citations · Full text

Medicine, Cell Biology, Orthopaedic Surgery +16